Pulmonary hypertension primary prevention
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension primary prevention On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension primary prevention |
|
Risk calculators and risk factors for Pulmonary hypertension primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable. PH that is secondary to other diseases such as left heart failure, chronic lung disease, chronic liver disease, and collagen vascular diseases among others can be prevented by the early and optimal treatment of these medical conditions. Patients who are at an elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with systemic sclerosis or with genetic predisposition.
Primary Prevention
- The primary prevention of the pulmonary hypertension is as follows:[1]
- Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable.
- PH that is secondary to other diseases such as left heart failure, chronic lung disease, chronic liver disease, and collagen vascular diseases among others can be prevented by the early and optimal treatment of these medical conditions.
- Patients who are at an elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with systemic sclerosis or with a genetic predisposition.
References
- ↑ Taichman DB, Ornelas J, Chung L, Klinger J, Lewis S, Mandel J; et al. (2014). "Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline". Chest. doi:10.1378/chest.14-0793. PMID 24937180.